Related references
Note: Only part of the references are listed.Provision of a Soy-Based Intravenous Lipid Emulsion at 1 g/kg/d Does Not Prevent Cholestasis in Neonates
Deepika Nehra et al.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2013)
The effect of lipid restriction on the prevention of parenteral nutrition-associated cholestasis in surgical infants
Sabrina E. Sanchez et al.
JOURNAL OF PEDIATRIC SURGERY (2013)
Effect of decreased parenteral soybean lipid emulsion on hepatic function in infants at risk for parenteral nutrition-associated liver disease: A pilot study
Michael D. Rollins et al.
JOURNAL OF PEDIATRIC SURGERY (2013)
High Rates of Resolution of Cholestasis in Parenteral Nutrition-Associated Liver Disease with Fish Oil-Based Lipid Emulsion Monotherapy
Muralidhar H. Premkumar et al.
JOURNAL OF PEDIATRICS (2013)
Phytosterols Promote Liver Injury and Kupffer Cell Activation in Parenteral Nutrition-Associated Liver Disease
Karim C. El Kasmi et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Intravenous Fat Emulsions Reduction for Patients with Parenteral Nutrition-Associated Liver Disease
Mary Petrea Cober et al.
JOURNAL OF PEDIATRICS (2012)
Parenteral fish-oil-based lipid emulsion improves fatty acid profiles and lipids in parenteral nutrition-dependent children
Hau D. Le et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2011)
Comparison of 5 intravenous lipid emulsions and their effects on hepatic steatosis in a murine model
Jonathan A. Meisel et al.
JOURNAL OF PEDIATRIC SURGERY (2011)
A double-blind, randomized clinical trial of the effect of ω-3 fatty acids on the oxidative stress of preterm neonates fed through parenteral nutrition
M. Skouroliakou et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2010)
New Intrauterine Growth Curves Based on United States Data
Irene E. Olsen et al.
PEDIATRICS (2010)
Very low birth weight preterm infants with surgical short bowel syndrome: Incidence, morbidity and mortality, and growth outcomes at 18 to 22 months
Conrad R. Cole et al.
PEDIATRICS (2008)
Could lipid infusion be a risk for parenteral nutrition-associated cholestasis in low birth weight neonates?
Jae I. I. Shin et al.
EUROPEAN JOURNAL OF PEDIATRICS (2008)
Stigmasterol, a soy lipid-derived phytosterol, is an antagonist of the bile acid nuclear receptor FXR
Beth A. Carter et al.
PEDIATRIC RESEARCH (2007)
Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease
R. D. Christensen et al.
JOURNAL OF PERINATOLOGY (2007)
Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children
V Colomb et al.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2000)
High plasma levels of phytosterols in patients on parenteral nutrition:: A marker of liver dysfunction
L Bindl et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2000)
Share Paper
